Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction

Molecular and Cellular Biochemistry

Volumn 394, Issue 1-2, 2014, Pages 137-144

  He, Fucheng ^a   Lv, Pin ^a   Zhao, Xue ^a   Wang, Xi ^a   Ma, Xuehan ^a   Meng, Weiwei ^a   Meng, Xianchun ^a   Dong, Shuling ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Circulating biomarkers; Diagnosis; MicroRNAs; Myocardial infarction; Prognosis

Indexed keywords

GENETIC MARKER; MICRORNA; MIRN134 MICRORNA, HUMAN; MIRN328 MICRORNA, HUMAN; TROPONIN T;

ADULT; AGED; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPLICATION; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; GENETIC MARKER; GENETICS; HEART FAILURE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK; RISK FACTOR; STATISTICAL MODEL; TIME; UPREGULATION;

ADULT; AGED; AREA UNDER CURVE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; GENETIC MARKERS; HEART FAILURE; HUMANS; LOGISTIC MODELS; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; ROC CURVE; TIME FACTORS; TROPONIN T; UP-REGULATION;

EID: 84939898533     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2089-0     Document Type: Article

References (38)

1. Hori M, Nishida K (2009) Oxidative stress and left ventricular remodeling after myocardial infarction. Cardiovasc Res 81:457–464
2. Sutton MG, Sharpe N (2000) Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101:2981–2988
3. White HD, Chew DP (2008) Acute myocardial infarction. Lancet 372:570–584
4. Jaffe AS, Ravkilde J, Roberts R et al (2000) It’s time for a change to a troponin standard. Circulation 102:1216–1220
5. Reichlin T, Hochholzer W, Bassetti S et al (2009) Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361:858–867
6. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136:215–233
7. Small EM, Olson EN (2011) Pervasive roles of microRNAs in cardiovascular biology. Nature 469:336–342
8. Meltzer PS (2005) Cancer genomics: small RNAs with big impacts. Nature 435:745–746
9. Sayed D, Abdellatif M (2011) MicroRNAs in development and disease. Physiol Rev 91:827–887
10. Gilad S, Meiri E, Yogev Y et al (2008) Serum microRNAs are promising novel biomarkers. PLoS ONE 3:e3148
11. Chen X, Ba Y, Ma L et al (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997–1006
12. Mitchell PS, Parkin RK, Kroh EM et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513–10518
13. Wang K, Zhang S, Weber J et al (2010) Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 38:7248–7259
14. Kuwabara Y, Ono K, Horie T et al (2011) Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 4:446–454
15. Corsten MF, Dennert R, Jochems S et al (2010) Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3:499–506
16. Devaux Y, Vausort M, Goretti E et al (2012) Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem 58:559–567
17. D’Alessandra Y, Devanna P, Limana F et al (2010) Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 31:2765–2773
18. Turchinovich A, Weiz L, Langheinz A et al (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39:7223–7233
19. Long G, Wang F, Duan Q et al (2012) Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS ONE 7:e50926
20. Hoekstra M, van der Lans CA, Halvorsen B et al (2010) The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun 394(3):792–797
21. Long G, Wang F, Duan Q et al (2012) Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci 8:811–818
22. Wang R, Li N, Zhang Y et al (2011) Circulating microRNAs are promising novel biomarkers of acute myocardial infarction. Intern Med 50:1789–1795
23. Thygesen K, Alpert JS, Jaffe AS et al (2012) Third universal definition of myocardial infarction. Eur Heart J 33:2551–2567
24. Grundy SM, Cleeman JI, Bairey CN et al (2004) Implications of recent clinical trials for the national cholesterol education pro-gram adult treatment panel III guidelines. Circulation 110:227–239
25. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101–1108
26. Lainscak M, Anker MS, von Haehling S et al (2009) Biomarkers for chronic heart failure: diagnostic, prognostic, and therapeutic challenges. Herz 34:589–593
27. Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD et al (2009) Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Am J Cardiol 103:1753–1759
28. Tijsen AJ, Pinto YM, Creemers EE (2012) Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol 303:H1085–H1095
29. Gao Y, Schug J, McKenna LB et al (2011) Tissue-specific regulation of mouse microRNA genes in endoderm-derived tissues. Nucleic Acids Res 39:454–463
30. Meder B, Keller A, Vogel B et al (2011) MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol 106(1):13–23
31. Fichtlscherer S, De Rosa S, Fox H et al (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107(5):677–684
32. Lu Y, Zhang Y, Wang N et al (2010) MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation 122(23):2378–2387
33. Delic S, Lottmann N, Stelzl A et al (2014) MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation. Neuro Oncol 16(2):179–190
34. Arora S, Ranade AR, Tran NL et al (2011) MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. Int J Cancer 129(11):2621–2631
35. Li C, Li X, Gao X et al (2014) MicroRNA-328 as a regulator of cardiac hypertrophy. Int J Cardiol 173(2):268–276
36. Miyamoto MI, del Monte F, Schmidt U et al (2000) Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci USA 97(2):793–798
37. Kumarswamy R, Lyon AR, Volkmann I et al (2012) SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway. Eur Heart J 33(9):1067–1075
38. Wiesen JL, Tomasi TB (2009) Dicer is regulated by cellular stresses and interferons. Mol Immunol 46:1222–1228